Skip to Content

Ultratard

Active Substance: insulin human
Common Name: insulin human (rDNA)
ATC Code: A10AE01
Marketing Authorisation Holder: Novo Nordisk A/S
Active Substance: insulin human
Status: Withdrawn
Authorisation Date: 2002-10-07
Therapeutic Area: Diabetes Mellitus
Pharmacotherapeutic Group: Drugs used in diabetes

Therapeutic Indication

Treatment of diabetes mellitus.

The marketing authorisation for Ultratard has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide